NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

908 Devices Inc. (MASS) Stock Analysis

908 Devices Inc. (MASS) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

MASS

$11.80

+$0.29 (+2.52%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MASS with… →

MASS Key Statistics

As of Oct 21, 2026
Trading
Open
$11.56
Previous Close
$11.51
Day's Range
11.44–11.96
52-Week Range
5.03–13.35
Volume
570.30K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.63
Valuation
Market Cap
$487.74M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
8.02
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.94
Financials (FY)
Revenue (FY)
$56.20M+17.70%
Net Income (FY)
$19.49M
Profit marginThe share of revenue left as profit after all costs and taxes.
−56.96%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
41.33M
1-Year Return
+34.55%
Dividend and dates
Earnings Date
November 10, 2026
Avg Volume
420.40K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, MASS closed at $11.80, +34.55% over 1 year.

908 Devices Inc. (MASS) has a market capitalization of $487.74M.

In fiscal 2025, MASS reported revenue of $56.20M.

MASS Stock Return by Calendar Year

908 Devices Inc. (MASS) return since Dec 2020: what $10,000 became

1 year
$10,000 $13,455
+34.55%
5 years
$10,000 $3,397
−66.03%
Since Dec 2020
$10,000 $2,408
−75.92%

If you had invested $10,000 in 908 Devices Inc. (MASS) at the close on December 18, 2020, the earliest close on record here, it would have been worth $2,408 at the close on October 21, 2026: −75.92% in total, −21.64% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+124.76%
2025+138.64%
2024−80.39%
2023+47.24%
2022−70.55%
2021−54.57%
2020 (partial year)+16.22%

As of October 21, 2026.

MASS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$56.20M$19.49M34.7%
2024$47.75M−$72.21M−151.2%
2023$50.23M−$36.40M−72.5%
2022$46.85M−$33.56M−71.6%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$56.20M$28.42M−$25.68M$19.49M34.7%
2024$47.75M$24.50M−$29.95M−$72.21M−151.2%
2023$50.23M$25.32M−$42.65M−$36.40M−72.5%
2022$46.85M$26.02M−$35.38M−$33.56M−71.6%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MASS Valuation vs Medical Devices Median

Median of 145 stocks
MetricMASSMedical Devices medianvs median
P/S ratio8.022.533.2x the median
Profit margin−56.96%−14.78%42.2 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 14 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

908 Devices Inc. (MASS) carries a market capitalisation of $487.74M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 172.

Over the past 52 weeks the price has ranged from $5.03 to $13.35. The most recent close on file for MASS is $11.80, dated October 21, 2026. That is +$0.29 (+2.52%) against the previous close. The latest close sits 134.83% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $56.20M. That is +17.70% against the prior fiscal year, when revenue was $47.75M. The same year closed with net income of $19.49M. The reported profit margin is −56.96%. That is 42.2 percentage points below the Medical Devices median of −14.78%. Trailing earnings per share are −0.94.

Across the 4 fiscal years on file, revenue moves from $46.85M in 2022 to $56.20M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 8.02. On price-to-sales that is 3.2 times the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

The trailing one-year total return is +34.55%. Across 5 years the annualized return works out at −19.42%. Beta against the wider market is reported at 0.63. Annualized volatility over the trailing 5 years is 94.8%.

Growth & Income

No dividend is on file for MASS.

Across the complete calendar years on file, 2025 returned +138.64% and 2024 returned −80.39%. Of the 5 complete calendar years on file, 2 finished higher. 2026 is still running; the total return is +124.76% year to date.

Peer Comparison

908 Devices Inc. (MASS) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
908 Devices Inc. MASS $487.74M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. 908 Devices Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About 908 Devices Inc.

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

Visit website →